egg counts had high inhibitory activity in their sera. In the 20-patient series, the 3 patients with prominent disease had high inhibitory activity in their sera. Evidence was obtained that IgG anti-S. japonicum antibodies (rather than circulating antigens, immune complexes, or anti-idiotypic antibodies) were most likely to be responsible for serum inhibitory activity in the test. No false-positive reactions have been obtained with pooled or individual sera from patients infected with numerous parasites other than S. japonicum, although no information is yet available on the inhibitory activities of sera from S. mansoni-or S. hematobium-infected individuals. On the basis of the data obtained to date, it is a reasonable prediction that the molecule or determinant to which this hybridoma antibody is directed will be a useful immunodiagnostic antigen for schistosomiasisjaponica in the Philippines. A test based on detection of serum antibodies to this antigen should have high specificity and may provide additional information on the level of infection or disease status in patients.
Serological methods have provided a useful supplement to fecal examination for eggs in the diagnosis of schistosomiasis. In the Philippines, the anti-egg circumoval precipitin (COP) test (1) has found wide use in the immunodiagnosis of schistosomiasis japonica (2) (3) (4) . The high sensitivity and specificity of this test have been demonstrated (5) , but quantitative determination of COP anti-egg antibody level is difficult, standardization of egg batches to be used is difficult, and the test provides little information on presumed infection levels in individual patients. Moreover, a recent study using a radioimmunoassay (RIA) with extracted Schistosomajaponicum egg antigens and 24 sera from the Philippines showed that titers of anti-egg antibodies do not correlate with fecal egg output (6) . In general, highest titers were found in infected teenagers and lowest titers were in older individuals. An Attempts. have been made to develop new IDTs for parasitic infection by using mouse. hybridomas that secrete antibodies reactive to antigens ofvarious parasites (7) (8) (9) (10) . By this approach, crossreacting hybridoma-derived antibodies can be used for depletion of shared antigens in parasite extracts (unpublished data) or highly specific antibodies can be used in competitive binding assays with sera (7, 8) or, eventually, for purification of immunodiagnostic antigens. The respective merits of these methods have been discussed (10) .
This paper reports that a hybridoma (designated IPH. 134 or, more correctly, the doubly cloned IPH. 134-18-6), selected from the fusion ofmodified myeloma cells with spleen cells from mice immunized against S. japonicum adult worms, secretes an antibody that has high immunodiagnostic potential. The binding of the labeled hybridoma-derived antibody to a crude adult worm extract (AWE) in a RIA is inhibited by at least 90% ofsera from individuals known to be infected with S. japonicum, and no false-positive reactions have yet been detected.
MATERIALS AND METHODS
Mice and Hybridomas. BALB/c mice to be used as donors of spleen cells for fusion were injected with S. japonicum eggs (6) or lyophilized, mouse-derived S. japonicum worms or extracts in Freund's complete adjuvant (Difco) and given booster injections without adjuvant at least twice. Spleen cells were taken for fusion at 4 days after the last antigen injection. The mice were derived from a specific pathogen-free facility but were maintained conventionally in the Melbourne laboratory (11) . Cells from mice infected with S.japonicum were also used for fusion in All methods used for production ofhybridomas (12) (13) (14) by using NS-1 myeloma cells have been described in detail (7 (Pharmacia) (7, 15) . They were labeled with 1"I by the chloramine-T method to a specific activity ofapproximately 370 kBq/ ,ug (i.e., 10 ,uCi/jug) by John Pye of this Institute.
RBIs. Three types ofsolid-phase RIA were used; the methods and sources of reagents have been described (7, 8, 16) . For direct-binding RIAs, a 50-,ul antigen titration was performed in borate buffer (pH 9.5) in polyvinyl chloride (PVC) plates and left for 3-4 hr at room temperature in a humidified box, unbound material was removed, and 50 ,ul of 0. 5% bovine serum albumin in mouse tonicity phosphate-buffered saline (pH 7.3) (Pi/NaCl) was added to each well. After 1 hr, plates were rinsed in 0.05% Tween 20 in Pi/NaCl, and approximately 20,000 cpm (50 p1) of "2I-labeled hybridoma antibody in Tween 20/albumin/Pi/NaCl was added to each well and left overnight at room temperature. Radioactivity in individual wells was determined in an Autogamma counter after the plates were rinsed and cut with a hot wire.
For competitive RIAs, an amount ofstock antigen was chosen for coating to the plates which resulted in 50-80% ofthe plateau level of binding of labeled hybridoma antibody. The procedure followed was the same as that described above except that, in the final step, 25 jil of solution containing 20,000 cpm of 125I-labeled hybridoma antibody was added to a 25 dul titration of antiserum (usually commencing at 1:20 dilution) in 0.05% Tween 20/0.5% albumin in Pi/NaCl. For selection of hybridomas, culture supernatants were treated for 3 hr with antigencoated plates followed by overnight incubation with an affinitypurified "2I-labeled sheep anti-mouse IgG antiserum which had Ig light chain as well as y and some tL heavy chain reactivities (16) . To examine the isotype of hybridoma antibody, labeled commercially available isotype-specific rabbit anti-Ig antisera were used (7) after purification on protein A-Sepharose.
Antigens for the RIAs were as follows. The S. japonicum AWE was prepared by homogenizing and sonicating lyophilized worms (derived from mice or rabbits) in borate buffer at pH 9.5. Any mouse Ig-binding molecules in the 12,000 X g supernatant (15 min) of this crude aqueous extract were depleted by passage through a normal-mouse Ig-Sepharose column; the run-through was collected and frozen at -20°C until used. This antigen-processing step was taken because of difficulties experienced in using crude worm extracts in the selection of hybridomas in various parasite systems in the past, difficulties that could be accounted for by binding of Ig to Fc receptor-like molecules in worm extracts. (Subsequently it was found that "2I-labeled IPH. 134 bound equally well to processed and unprocessed S. japonicum AWE.) Preparation ofthe S.japonicum aqueous egg extract has been described (6) prepared from bulk cultures), when labeled with i25I, was found to bind to a processed AWE of S. japonicum but not at all to a S. mansoni AWE or to other crude antigen mixtures from helminths and protozoa that can infect man (e.g., F. hepatica, P. westermanii, C. sinensis, A. cantonensis, E. granulosus, T. saginata, P.falciparum, and L. tropica). Some ofthese antigens were used in the solid-phase RIA at a protein concentration 1000 times that of S. japonicum AWE (Fig. 1). 125I-Labeled IPH. 134 was found not to bind to aS japonicum egg antigen extract in the solid-phase RIA. An IgGl anti-egg hybridoma antibody, SEF.85-5-3, did bind to this same antigen preparation (or to S. japonicum AWE), indicating that at least one antigen was present in the egg extract. Moreover, this same egg antigen preparation had been used successfully for screening human sera in a previous study (6) .
Inhibition of Binding of "MI-Labeled IPH. 134 to S. japonicum AWE by Sera from Infected Patients. COP-positive sera were available from 19 known infected individuals in the Philippines: they had been tested previously for anti-egg antibodies in an RIA (6) . They were screened for inhibitory activity by using 125I-labeled IPH. 134-18-6 and the S. japonicum AWE. No false-negative reactions were observed, although sera differed markedly in their inhibitory activity. Four pools of sera (three from the Philippines and one from Melbourne), made up from individuals known not to have schistosomiasis japonica, were negative in the assay (Fig. 2) . When sera from the infected patients were ranked according to level of inhibitory serum activity (Table 1) , the four patients with relatively high fecal egg counts had high inhibitory activity in serum (i.e., sera 27, 1, 3, and 5). The other serum with high inhibitory activity (serum 22) (Fig. 2) ] was >50 times higher. No inhibitory activity was found in the run-through fraction of the protein A-Sepharose column. Serum 3 (high inhibitory titer) was fractionated on SF-300, and again a marked hypergammaglobulinemia was evident. When fractions were assayed in the competitive RIA, inhibitory activity coincided precisely with the large IgG peak, and none was detected in the IgM or albumin regions of the protein profile. The lack of inhibitory activity in fractions other than those containing IgG proteins in the SF-300 fractionation and the protein A-Sepharose runthrough fraction does not support the notion that inhibitory activity in these sera is mediated by immune complexes or circulating antigen in the schistosomiasis sera (19, 20) In another series involving 20 COP-positive sera (Table 2) , inhibitory titers again varied widely. Unlike the previous series (Table 1; Fig. 2 ), no suggestive association between high egg output and high inhibitory serum activity was detected. However, the three individuals with both splenomegaly and hepatomegaly (i.e., prominent disease) had the highest levels of inhibitory activity in their sera. Four of the sera were negative in the assay. Thus, the false-negative rate is approximately 10%, based on a total of 19 + 20 + 3 additional sera (i.e., 42) screened. None of the four false-negative individuals had high fecal egg outputs and no disease was recorded in the two from whom clinical data are available (Table 2) .
Search for False-Positive Reactions. In addition to the control Philippine and Australian serum pools used (Fig. 2) , pools or individual sera from 33 patients with elephantiasis (3 sera), malaria (10 sera as a pool), paragonimiasis (4 sera as a pool), fascioliasis (2 sera), hydatids (4 sera), suspected toxocariasis (3 sera), or cysticercosis (5 sera) from Papua New Guinea, Peoples Republic ofChina, Australia, and the Philippines were screened for inhibitory activity. No inhibitory activity (even at 1:10 or 1:20 dilution of serum) was detected in the assay using S.japonicum AWE and '251-labeled IPH. 134 except that, at the lowest dilution, the three sera from children with suspected toxocariasis had low inhibitory activity (<20%).
When three other hybridoma-derived antibodies with binding activity for S japonicum AWE were used in the competitive RIA with "MI-labeled IPH. 134, no inhibition of binding was found. These antibodies presumably are directed against antigenic determinants other than the determinant to which IPH. 134 is directed. 
